China Pharma has scalable GMP-certified manufacturing facilities with eight different modern production lines. These facilities passed the GMP-certification when it was first introduced in 2003 and passed the latest round in 2008. The GMP-certification is repeated every five years.
In 2008 the Company invested $3.0 million to increase capacity of the dry powder line. China Pharma¨s cutting edge production lines can manufacture products in the following forms of delivery: tablets; capsules; injectables; granules; oral fluids (suspension); and freeze dried (lyophilized injectables). Its production capacity fully satisfies the needs of the current portfolio.